Imidazoline binding sites in the endocrine pancreas: can they fulfil their potential as targets for the development of new insulin secretagogues?
Curr Pharm Des. 2001 Sep;7(14):1413-31. doi: 10.2174/1381612013397366.
Curr Pharm Des. 2001.
PMID: 11472276
Review.